¥**** +***% +****
Volume: **** million
Turnover: *** billion
Total market value: *** billion
Market capitalization: ** billion
****年*月**日 **** Real-time information
Dr. Hongbin Sun, Ph.D
Independent Non-executive Director
Dr.Sun was designed as an Independent Non-executive Director in 2019.
Dr. Sun is a Professor and Director of the Key Laboratory of Metabolic Diseases in Jiangsu Province, and Deputy Director of the State Key Laboratory of Natural Active Pharmaceuticals and Pharmacodynamics of China Pharmaceutical University. Dr. Sun is also the Distinguished Professor of the ‘Yangtze River Scholars Awards Program’ of the Ministry of Education of China, the head of the pharmacology expert group of the ‘13th Five-Year Plan Strategy Research’ of the Department of Medical Sciences of the National Natural Science Foundation of China and Member of the Chinese Pharmaceutical Association's Medicinal Chemistry Committee.
Dr. Sun obtained Ph.D. from China Pharmaceutical University in July 1995. From 1995 to 2001, Dr. Sun conducted Postdoctoral Research at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, RWTH Aachen University, and the University of Florida.
Dr. Sun is currently Independent Director of Zhejiang Jianfeng Group Co., Ltd. (stock code: 600668).